![]() |
|
|
RESÚMENES NOVIEMBRE 2009 |
Mood - Anxiety
Disorders & Antidepressants – Mood Stabilizers
(Haga un click
en la información del journal para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3 - Mecamylamine – a nicotinic acetylcholine
receptor antagonist with potential for the treatment of neuropsychiatric
disorders
Ingrid Bacher
Expert
Opinion on Pharmacotherapy. November 2009, Vol. 10, No. 16, Pages 2709-2721
5< - Differential effects of escitalopram on attention:
a placebo-controlled, double-blind cross-over study
Barbara Drueke,
Julia Baetz, Maren Boecker, Olaf Moeller, Christoph Hiemke,
Gerd Gründer and Siegfried Gauggel
Psychopharmacology. Volume 207, Number 2 / December,
2009: 213-223
3 - Anxiety
and Outcome in Bipolar Disorder
William Coryell, David A.
Solomon, Jess G. Fiedorowicz, Jean Endicott, Pamela J. Schettler, and Lewis L.
Judd
Am J Psychiatry 2009; 166:1238-1243
3! - Cognitive Behavioral
Analysis System of Psychotherapy and Brief Supportive Psychotherapy for
Augmentation of Antidepressant Nonresponse in Chronic Depression. The REVAMP
Trial
James H. Kocsis, Alan J.
Gelenberg, Barbara O. Rothbaum, Daniel N. Klein, Madhukar H. Trivedi, Rachel
Manber, Martin B. Keller, Andrew C. Leon, Steven R. Wisniewski, Bruce A. Arnow,
John C. Markowitz, Michael E. Thase, for the REVAMP Investigators
Arch Gen Psychiatry. 2009;66(11):1178-1188
3 -
Pharmacokinetic/Pharmacodynamic Modeling of Psychomotor Impairment Induced by
Oral Clonazepam in Healthy Volunteers
Santos, Fábio Monteiro dos;
Gonçalves, José Carlos Saraiva; Caminha, Ricardo; da Silveira, Gabriel
Estolano; Neves, Claúdia Silvana de Miranda; Gram, Karla Regina da Silva;
Ferreira, Carla Teixeira; Jacqmin, Philippe; Noël, François
Therapeutic Drug Monitoring:
October 2009 - Volume 31 - Issue 5 - pp 566-574
3 -
Formulations of Valproate Alter Valproate Metabolism: A Single Oral Dose
Kinetic Study
Nagai, Goyo; Ono, Shingo;
Yasui-Furukori, Norio; Nakamura, Akifumi; Mihara, Kazuo; Kondo, Tsuyoshi
Therapeutic Drug Monitoring:
October 2009 - Volume 31 - Issue 5 - pp 592-596
3! - Critical appraisal and update on the clinical utility of agomelatine, a
melatonergic agonist, for the treatment of major depressive disease in adults
Robert H Howland
Neuropsychiatric Disease and Treatment. Published Date
November 2009
3! - Effects of Glucocorticoids on Mood, Memory, and the
Hippocampus. Treatment and Preventive Therapy
E. Sherwood Brown
Annals
of the New York Academy of Sciences. 2009; Volume 1179, Pages 41 - 55
3! - Sex Hormones and Mood in the Perimenopause
Peter J. Schmidt and David
R. Rubinow
Annals
of the New York Academy of Sciences. 2009; Volume
1179, Pages 70 - 85
3! - Cytokines and Glucocorticoid Receptor Signaling. Relevance
to Major Depression
Thaddeus W. W. Pace and Andrew
H. Miller
Annals
of the New York Academy of Sciences. 2009; Volume 1179, Pages 86 - 105
3 - CRH Signaling. Molecular Specificity for Drug
Targeting in the CNS
Damian Refojo and Florian Holsboer
Annals
of the New York Academy of Sciences. 2009; Volume
1179, Pages 106 - 119
3! - Risk Factors for Development of Depression and
Psychosis. Glucocorticoid Receptors and Pituitary Implications for Treatment
with Antidepressant and Glucocorticoids
Carmine M. Pariante
Annals
of the New York Academy of Sciences. 2009; Volume
1179, Pages 144 - 152
3! - Galantamine-ER For Cognitive Dysfunction In Bipolar
Disorder and Correlation with Hippocampal Neuronal Viability: A
Proof-of-Concept Study
Dan V. Iosifescu, Constance M. Moore, Thilo Deckersbach , Claire A. Tilley, Michael J. Ostacher, Gary S. Sachs, & Andrew A. Nierenberg
CNS Neuroscience &
Therapeutics. Volume 15 Issue 4, Pages 309 - 319
3 - Potential Mechanisms Involved in the Prevention of
Neurodegenerative Diseases by Lithium
Antoni Camins, Ester Verdaguer,
Felix Junyent,
Marc Yeste-Velasco,
Carme Pelegrí,
Jordi Vilaplana & Mercé Pallás
CNS
Neuroscience & Therapeutics. Volume 15 Issue
4, Pages 333 - 344
3 - Nitric oxide mechanism in protective effect of
imipramine and venlafaxine against acute immobilization stress-induced
behavioral and biochemical alteration in mice
Anil
Kumar, Ruchika Garg, Vaibhav Gaur and Puneet Kumar
Neuroscience Letters. Volume
467, Issue 2, 25 December 2009, Pages 72-75
3 - Desipramine induced changes in the norepinephrine
transporter, α- and γ-synuclein in the
hippocampus, amygdala and striatum
Alexis M. Jeannotte, John G. McCarthy and Anita Sidhu
Neuroscience
Letters. Volume 467, Issue 2, 25 December 2009, Pages 86-89
3! - Early onset anxiolytic efficacy after a single
dose of pregabalin: double-blind, placebo- and active-comparator controlled
evaluation using a dental anxiety model
D. Nutt, F.
Mandel, F. Baldinetti
Journal of Psychopharmacology, Vol. 23, No. 8, 867-873
(2009)
3 - Antimanic potency of typical neuroleptic drugs and
affinity for dopamine D2 and serotonin 5-HT2A receptors — a new analysis of
data from the archives and implications for improved antimanic treatments
PE
Harrison-Read
Journal
of Psychopharmacology, Vol. 23, No. 8, 899-907 (2009)
3 - Sex-related differential response to clomipramine
treatment in a rat model of depression
N.
Kokras, K. Antoniou, C. Dalla, S. Bekris, M. Xagoraris, DH Ovestreet, Z.
Papadopoulou-Daifoti
Journal of Psychopharmacology, Vol. 23, No. 8, 945-956
(2009)
3 - Is phosphoadenosine phosphate phosphatase a target
of lithium’s therapeutic effect?
G. Shaltiel,
J. Deutsch, S. I. Rapoport, M. Basselin,
R. H. Belmaker and G. Agam
Journal
of Neural Transmission. Volume 116, Number 11 / November, 2009: 1543-1549
4 -
Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being
Outcome Measures in Patients With Major Depressive Disorder: A Pooled Analysis
of 9 Double-Blind, Placebo-Controlled, 8-Week Clinical Trials
Claudio N. Soares, Susan G.
Kornstein, Michael E. Thase, Qin Jiang, and Christine J. Guico-Pabia
J Clin Psychiatry 2009;70(10):1365–1371
4 - Olanzapine/Fluoxetine
Combination for the Treatment of Mixed Depression in Bipolar I Disorder: A Post
Hoc Analysis
Franco
Benazzi, Michael Berk, Mark A. Frye, Wei Wang, Alessandra Barraco, and Mauricio
Tohen
J Clin Psychiatry 2009;70(10):1424–1431
3 - Vilazodone, a novel dual-acting serotonergic
antidepressant for managing major depression
Arif Khan
Expert
Opinion on Investigational Drugs. November 2009, Vol. 18, No. 11, Pages
1753-1764
3! - Meta-analysis of initial seizure thresholds in
electroconvulsive therapy
Jeroen A. van Waarde,
Bastiaan Verwey and Rose C. van der Mast
3 - Effects of antidepressants on plasma metabolites of
nitric oxide in major depressive disorder: Comparison between milnacipran and
paroxetine
Atsuko
Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, Wakako Umene-Nakano, Nobuhisa
Ueda and Jun Nakamura
3! - Folic acid efficacy as an alternative drug added to
sodium valproate in the treatment of acute phase of mania in bipolar disorder:
a double-blind randomized controlled trial
A. H. Behzadi, Z. Omrani,
M. Chalian,
S. Asadi,
M. Ghadiri
Acta
Psychiatrica Scandinavica. Volume 120 Issue
6, Pages 441 - 445
3! - Is bipolar II depression phenotypically distinctive?
G. B. Parker, K. Fletcher
Acta
Psychiatrica Scandinavica. Volume 120 Issue
6, Pages 446 - 455
3 - The neurocognitive performance of drug-free and
medicated euthymic bipolar patients do not differ
U. Goswami, A. Sharma, A. Varma, C. Gulrajani, I.
N. Ferrier, A. H. Young,
P. Gallagher,
J. M. Thompson,
P. B. Moore
Acta
Psychiatrica Scandinavica. Volume 120 Issue
6, Pages 456 - 463
3 - Gender differences in bipolar disorder type I and II
K. Suominen, O. Mantere,
H. Valtonen,
P. Arvilommi,
S. Leppämäki,
E. Isometsä
Acta
Psychiatrica Scandinavica. Volume 120 Issue
6, Pages 464 - 473
4 - Number
Needed to Treat or Harm Analyses of Olanzapine for Maintenance Treatment of
Bipolar Disorder
Tohen, Mauricio; Sniadecki,
Jennifer; Sutton, Virginia K; Degenhardt, Elisabeth K; Karagianis, Jamie L;
Sagman, Doron; Jacobson, Jennie G
Journal
of Clinical Psychopharmacology: December 2009 - Volume 29 - Issue 6 - pp 520-528
3! -
Antidepressant Use During Pregnancy and the Risk of Preterm Delivery and Fetal
Growth Restriction
Toh, Sengwee; Mitchell, Allen
A; Louik, Carol; Werler, Martha M; Chambers, Christina D; Hernández-Díaz, Sonia
Journal
of Clinical Psychopharmacology: December 2009 - Volume 29 - Issue 6 - pp
555-560
5< - A
Randomized Controlled Trial of Atomoxetine in Generalized Social Anxiety
Disorder
Ravindran, Lakshmi N; Kim,
Daniel S; Letamendi, Andrea M; Stein, Murray B
Journal
of Clinical Psychopharmacology: December 2009 - Volume 29 - Issue 6 - pp
561-564
3 -
Depressive Symptomatology, Rather than Neuroticism, Predicts Inflated Physical
Symptom Reports in Community-Residing Women
M. Bryant Howren, Jerry Suls, and René Martin
Psychosomatic
Medicine 71:951-957 (2009)
GRATIS 3 - Do Depressed Patients With
Diabetes Experience More Side Effects When Treated With Citalopram Than Their
Counterparts Without Diabetes? A STAR*D Study
Charlene
Bryan, Thomas Songer, Maria Mori Brooks, Michael E. Thase, Bradley Gaynes,
Michael Klinkman, G. K. Balasubramani, A. John Rush, Madhukar H. Trivedi,
Maurizio Fava, and Stephen R. Wisniewski
Prim Care Companion J Clin Psychiatry
2009;11(5):186-196
GRATIS 4 - Quetiapine Monotherapy as
Treatment for Anxiety Symptoms in Patients With Bipolar Depression: A Pooled
Analysis of Results From 2 Double-Blind, Randomized, Placebo-Controlled Studies
R.
Bruce Lydiard, Larry Culpepper, Helena Schiöler, Urban Gustafsson, and Björn
Paulsson
Prim Care Companion J Clin Psychiatry
2009;11(5):215225
GRATIS 3 - Augmentation Effect of
Repetitive Transcranial Magnetic Stimulation Over the Orbitofrontal Cortex in
Drug-Resistant Obsessive-Compulsive Disorder Patients: A Controlled
Investigation
Chiara
Ruffini, Marco Locatelli, Adelio Lucca, Francesco Benedetti, Chiara Insacco,
and Enrico Smeraldi
Prim Care Companion J Clin Psychiatry 2009;11(5):226230
3 -
Does improving mood in depressed patients alter factors that may affect
cardiovascular disease risk?
C.
Barr Taylor, Ansgar Conrad, Frank H. Wilhelm, Diane Strachowski, Anna Khaylis,
Eric Neri, Janine Giese-Davis, Walton T Roth, John P. Cooke, Helena Kraemer and
David Spiegel
Journal of Psychiatric Research. Volume 43, Issue 16,
December 2009, Pages 1246-1252
5 - Asenapine versus olanzapine in acute mania: a double-blind extension
study
Roger S McIntyre, Miriam Cohen, Jun Zhao, Larry Alphs, Thomas A Macek and
John Panagides
Bipolar Disorders. Volume
11 Issue 8, Pages 815 - 826
5 - A
randomized, double-blind, placebo-controlled study of maintenance treatment
with adjunctive risperidone long-acting therapy in patients with bipolar I
disorder who relapse frequently
Wayne Macfadden, Larry Alphs,
J Thomas Haskins, Norris Turner, Ibrahim Turkoz, Cynthia Bossie, Mary Kujawa and
Ramy Mahmoud
Bipolar Disorders. Volume
11 Issue 8, Pages 827 - 839
3 -
Stability of symptoms across major depressive episodes in bipolar disorder
Roy H Perlis, Michael J Ostacher,
Rudolf Uher, Andrew A Nierenberg, Francesco Casamassima,
Christine Kansky, Joseph R Calabrese, Michael Thase, Gary
S Sachs
Bipolar Disorders. Volume
11 Issue 8, Pages 867 - 875
3! -
Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine,
but not valproate, may be related to their antidepressant effect
Liad Mann, Eliahu Heldman,
Yuly Bersudsky,
Stephen F Vatner, Yoshihiro Ishikawa, Orna Almog, Robert
H Belmaker, Galila Agam
Bipolar Disorders. Volume
11 Issue 8, Pages 885 - 896
GRATIS 3! -
Pharmacological and combined interventions for the acute depressive episode:
focus on efficacy and tolerability
Andre R Brunoni, Renerio
Fraguas Jr, Felipe Fregni
Therapeutics and Clinical Risk Management. Published
Date November 2009
3 - Depressive Symptoms and Metabolic Syndrome:
Selective Association in Older Women
Alice Laudisio, Emanuele
Marzetti, Francesco Pagano, Gino Pozzi, Roberto Bernabei, Giuseppe Zuccalà
Journal
of Geriatric Psychiatry and Neurology, Vol. 22, No. 4, 215-222 (2009)
5 - The
General and Comparative Efficacy and Safety of Duloxetine in Major Depressive
Disorder: A Systematic Review and Meta-Analysis
Gartlehner, Gerald; Thaler,
Kylie; Hansen, Richard A; Gaynes, Bradley N
Drug Safety: 1 December 2009 - Volume 32 - Issue 12 -
pp 1159-1173
5< - Effects of
the GABA-reuptake Inhibitor Tiagabine on Panic and Anxiety in Patients with
Panic Disorder
P. Zwanzger,
D. Eser, C. Nothdurfter, T. C. Baghai, H.-J. Möller,
F. Padberg, R. Rupprecht
Pharmacopsychiatry
2009; 42: 266-269
GRATIS 3 - Pharmacotherapy
of Major Depressive Disorder: Focus on Duloxetine
Katsumasa
Muneoka
Clinical Medicine: Therapeutics 2009:1 1541-1556
3 -
Preliminary Findings Concerning the Use of Prazosin for the Treatment of
Posttraumatic Nightmares in a Refugee Population
Boynton, Lorin; Bentley, Jacob;
Strachan, Eric; Barbato, Anna; Raskind, Murray
Journal of Psychiatric Practice: November 2009 -
Volume 15 - Issue 6 - pp 454-459
2! -
Medically Unexplained Physical Symptoms in Elderly People: A Pilot Study of
Psychiatric Geriatric Characteristics
Hilderink, Peter H; Benraad,
Caroline E; van Driel, Dorine; Buitelaar, Jan K; Speckens, Anne E; Olde Rikkert,
Marcel G; Voshaar, Richard C. Oude
American
Journal of Geriatric Psychiatry: December 2009 - Volume 17 - Issue 12 - pp
1085-1088
GRATIS 3 - Modifiable risk factors predicting major
depressive disorder at four year follow-up: a decision tree approach
Philip
J Batterham, Helen Christensen and Andrew
J Mackinnon
3 -
Electroconvulsive therapy increases glial cell-line derived neurotrophic factor
(GDNF) serum levels in patients with drug-resistant depression
Xiaobin
Zhang, Zhijun Zhang, Weiwei Sha, Chunming Xie, Guangjun Xi, Honghui Zhou and Yumei Zhang
Psychiatry Research. Volume 170, Issues 2-3, 30 December 2009,
Pages 273-275
3 - Effects of acute and sustained administration of
the catecholamine reuptake inhibitor nomifensine on the firing activity of
monoaminergic neurons
Noam S Katz, Bruno P
Guiard, Mostafa El Mansari, and Pierre Blier
Journal of Psychopharmacology. First published on
November 25, 2009
5 - Double-blind, placebo-controlled comparison of the
antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
Karen Hewett, Michelle D.
Gee, Alok Krishen, Hans-Peter Wunderlich, Alfred Le Clus, Gary Evoniuk, and
Jack G. Modell
Journal of Psychopharmacology. First published on
November 25, 2009
3 - Longitudinal changes of day-time and night-time
gross motor activity in clinical responders and non-responders of major
depression
Doron Todder
World Journal of Biological
Psychiatry. 2009, Vol. 10, No. 4, Pages 276-284
3 - Cortical neurochemistry in euthymic patients with
bipolar I disorder
Harald Scherk
World Journal of Biological
Psychiatry. 2009, Vol. 10, No. 4, Pages 285-294
3 - Pro-inflammatory biomakers in depression:
Treatment with venlafaxine
John E. Piletz, Angelos Halaris
World Journal of Biological
Psychiatry. 2009, Vol. 10, No. 4, Pages 313-323
3 - Depressive disorder and thyroid axis functioning
during pregnancy
Robertas Bunevicius, Laima Kusminskas
World Journal of Biological
Psychiatry. 2009, Vol. 10, No. 4, Pages 324-329
3 - Chronic stress and antidepressant treatment have
opposite effects on P-glycoprotein at the blood–brain barrier: an experimental
PET study in rats
Onno L. de Klerk, Fokko J
Bosker, Antoon T. M. Willemsen, Aren van Waarde, Anniek K. D. Visser, Tim de
Jager, Girstaute Dagyte, Johan A. den Boer, Rudi A Dierckx, and Peter Meerlo
Journal of Psychopharmacology. First published on
November 26, 2009
3 -
Diencephalic Serotonin Transporter Availability Predicts Both Transporter
Occupancy and Treatment Response to Sertraline in Obsessive-Compulsive Checkers
Werner
Zitterl, Thomas Stompe, Martin Aigner, Karin Zitterl-Eglseer, Kristina Ritter,
Georg Zettinig, Kurt Hornik, Susanne Asenbaum, Walter Pirker and Kenneth Thau
Biological Psychiatry. Volume 66, Issue 12, 15 December 2009, Pages
1115-1122
3 -
Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder
Ditte
Dencker and Henriette Husum
Behavioural
Brain Research. Volume 207, Issue 1, 11 February 2010, Pages 78-83
3 - Acute administration of leptin produces
anxiolytic-like effects: a comparison with fluoxetine
Jing Liu,
Jacob C. Garza, Jamaur Bronner, Chung Sub Kim,
Wei Zhang and Xin-Yun Lu
Psychopharmacology. Volume 207, Number 4 / January,
2010: 535-545
5< - Effects of paroxetine on emotional functioning and
treatment awareness: a 4-week randomized placebo-controlled study in healthy
clinicians
Nathalie Besnier,
Catherine Cassé-Perrot, Elisabeth Jouve, Nhan Nguyen,
Christophe Lançon, Bruno Falissard and Olivier Blin
Psychopharmacology. Volume 207, Number 4 / January,
2010: 619-629
3 - Pre-, Peri- and Postpartal Depression.
First Cognition from FRAMES
(Franconian Maternal Health Evaluation Studies)
U. Reulbach,
S. Bleich, J. Knörr, P. Burger, P. A. Fasching,
J. Kornhuber, M. W. Beckmann, T. W. Goecke
Fortschr
Neurol Psychiatr 2009; 77: 708-713
GRATIS (previo registro)
3 -
Uso de los tratamientos antidepresivos. La percepción del paciente
M. J. Martín, M. García-Toro, F. Campoamor, A. Pareja, I. Aguirre, J. Salvá y M. Roca
Actas Esp Psiquiatr 2009;37(5):276-281
GRATIS (previo registro)
3 -
Pronóstico de la depresión en la tercera edad en comparación con la edad
adulta. ¿Existe una diferencia clínica significativa?
A. J. Mitchell y A.
Izquierdo de Santiago
Actas Esp Psiquiatr 2009;37(5):289-296
GRATIS 3! - Is Monotherapy as Good as
Polypharmacy in Long-Term Treatment of Bipolar Disorder?
Martin
Alda, Lakshmi N Yatham
Can J Psychiatry. 2009;54(11):719–725
GRATIS 3! - Mechanism
of Action of Trazodone: a Multifunctional Drug
Stephen
M. Stahl
CNS Spectr. 2009;14(8):412-414
GRATIS (previo registro)
3 - Depression has a Strong Relationship to Alterations in the Immune,
Endocrine and Neural System
Knut A. Hestad, Pal Aukrust, Sverre Tonseth,
Solveig Klæbo Reita
Current Psychiatry Reviews.
2009; Volume 5 Issue 4: 287-297
GRATIS (previo registro)
3 - The
Role of Dopaminergic Agents in Improving Quality of Life in Major Depressive
Disorder
Current Psychiatry Reports 2009, 11: (6) 503-508
GRATIS (previo registro)
3! - Melatonin,
Circadian Rhythms, and the Clock Genes in Bipolar Disorder
Current Psychiatry Reports 2009, 11: (6) 488-493
GRATIS (previo registro)
3! - Impulsivity
in Mania
Current Psychiatry Reports 2009, 11: (6) 481-487
GRATIS (previo registro)
3 - Mania and Mortality: Why the Excess
Cardiovascular Risk in Bipolar Disorder?
Current Psychiatry Reports 2009, 11: (6) 475-480
GRATIS (previo registro)
3 - Exercise in the Treatment of Depression
Current Psychiatry Reports 2009, 11: (6) 466-472
GRATIS (previo registro)
3! - Circadian
Misalignment in
Mood Disturbances
Current Psychiatry Reports 2009, 11: (6) 459-465
GRATIS (previo registro)
3 - Transcranial
Magnetic Stimulation in the Treatment of Psychiatric Disorders
Current Psychiatry Reports 2009, 11: (6) 447-452
GRATIS (previo registro)
3 - Pregnancy
and Depression: Exploring a New Potential Treatment Option
Current Psychiatry Reports 2009, 11: (6) 443-446
GRATIS (previo registro)
3 - Insomnia
and Depression: A Multifaceted Interplay
Current Psychiatry Reports 2009, 11: (6) 437-442
GRATIS (previo registro)
3 - Anxious
Depression: Clinical Features and Treatment
Current Psychiatry Reports 2009, 11: (6) 429-436
GRATIS 3 - Depression During Pregnancy
Katherine
L. Wisner
| Regresar a RESÚMENES NOVIEMBRE 2009 |
© 1999-2009 Jorge M
Tamayo, MD, BMSS
Creada en Enero 1999
Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.